We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+39.26%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$995M
AUM Growth
+$197M
Cap. Flow
-$505K
Cap. Flow %
-0.05%
Top 10 Hldgs %
92.32%
Holding
20
New
2
Increased
4
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
FOLD
Amicus Therapeutics
FOLD
+$16.3M
2
AERI
Aerie Pharmaceuticals
AERI
+$7.07M
3
GKOS icon
Glaukos
GKOS
+$1.34M
4
VYNE icon
VYNE Therapeutics
VYNE
+$816K
5
KIDS icon
OrthoPediatrics
KIDS
+$614K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$16.4M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$10.2M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$165K

Sector Composition

Rank Sector Weight
1 Healthcare 95.17%
2 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INGN icon
1
Inogen
INGN
$169M
$661M 66.5%
3,549,320
– –
XLRN
2
DELISTED
Acceleron Pharma
XLRN
$53.6M 5.39%
1,103,937
-450,000
-29% -$16.4M
CRVS icon
3
Corvus Pharmaceuticals
CRVS
$1.12B
$48.5M 4.88%
4,420,516
– –
MRUS
4
DELISTED
Merus
MRUS
$32.1M 3.23%
1,410,417
– –
AKBA icon
5
Akebia Therapeutics
AKBA
$338M
$30.9M 3.11%
3,100,000
– –
GKOS icon
6
Glaukos
GKOS
$9.12B
$24.5M 2.46%
602,709
+37,544
+7% +$1.34M
DERM
7
DELISTED
Dermira, Inc.
DERM
$18.3M 1.84%
1,993,746
– –
KIDS icon
8
OrthoPediatrics
KIDS
$506M
$17.4M 1.75%
653,349
+28,758
+5% +$614K
FOLD
9
DELISTED
Amicus Therapeutics
FOLD
$16.9M 1.7%
+1,081,181
New +$16.3M
RARX
10
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$14.6M 1.47%
1,465,838
– –
SPNE
11
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11.7M 1.18%
927,788
+7,408
+0.8% +$88.7K
VYNE icon
12
VYNE Therapeutics
VYNE
$16.4M
$11.7M 1.17%
399
+21
+6% +$816K
VRNA
13
DELISTED
Verona Pharma
VRNA
$10.1M 1.02%
740,740
– –
NBRV
14
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.1M 1.01%
11,555
-144
-1% -$165K
COGT icon
15
Cogent Biosciences
COGT
$6.99B
$9.54M 0.96%
166,295
– –
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$8.54M 0.86%
+126,397
New +$7.07M
WMGIZ
17
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
– –
0
– –
IVTY
18
DELISTED
Invuity, Inc
IVTY
$5.32M 0.53%
1,363,848
– –
C icon
19
Citigroup
C
$225B
– –
0
– –
CRSP icon
20
CRISPR Therapeutics
CRSP
$4.72B
– –
-223,317
Closed -$10.2M

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q2 2018 Portfolio in Review

As of Q2 2018, Novo Holdings A/S held 20 positions worth $995M, up 25% from $797M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Novo Holdings A/S's Q2 2018 filing shows 2 new, 4 increased, 2 reduced and 1 closed positions. Its largest new stake was Amicus Therapeutics: 1,081,181 shares worth $16.9M. The largest sale was Acceleron Pharma, an estimated $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Financials.

  • Novo Holdings A/S's largest Q2 2018 buy was Amicus Therapeutics: 1,081,181 shares worth $16.9M.
  • Novo Holdings A/S added most to Glaukos in Q2 2018, an estimated $1.34M increase.
  • Novo Holdings A/S's biggest Q2 2018 reduction was Acceleron Pharma, cutting an estimated $16.4M.
  • Novo Holdings A/S fully exited CRISPR Therapeutics in Q2 2018, selling an estimated $10.2M.
  • Novo Holdings A/S's ten largest holdings make up 92% of its $995M portfolio in Q2 2018.
  • Novo Holdings A/S opened 2 new positions and closed 1 in Q2 2018.
  • Novo Holdings A/S's portfolio value rose 25% quarter-over-quarter to $995M.

Based on Novo Holdings A/S's 13F filing for Q2 2018, filed 14 Aug 2018.